Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Diabetes Metab Syndr. 2024 Apr;18(4):103003. doi: 10.1016/j.dsx.2024.103003. Epub 2024 Apr 3.
To build a facial image database and to explore the diagnostic efficacy and influencing factors of the artificial intelligence-based facial recognition (AI-FR) system for multiple endocrine and metabolic syndromes.
Individuals with multiple endocrine and metabolic syndromes and healthy controls were included from public literature and databases. In this facial image database, facial images and clinical data were collected for each participant and dFRI (disease facial recognition intensity) was calculated to quantify facial complexity of each syndrome. AI-FR diagnosis models were trained for each disease using three algorithms: support vector machine (SVM), principal component analysis k-nearest neighbor (PCA-KNN), and adaptive boosting (AdaBoost). Diagnostic performance was evaluated. Optimal efficacy was achieved as the best index among the three models. Effect factors of AI-FR diagnosis were explored with regression analysis.
462 cases of 10 endocrine and metabolic syndromes and 2310 controls were included into the facial image database. The AI-FR diagnostic models showed diagnostic accuracies of 0.827-0.920 with SVM, 0.766-0.890 with PCA-KNN, and 0.818-0.935 with AdaBoost. Higher dFRI was associated with higher optimal area under the curve (AUC) (P = 0.035). No significant correlation was observed between the sample size of the training set and diagnostic performance.
A multi-ethnic, multi-regional, and multi-disease facial database for 10 endocrine and metabolic syndromes was built. AI-FR models displayed ideal diagnostic performance. dFRI proved associated with the diagnostic performance, suggesting inherent facial features might contribute to the performance of AI-FR models.
建立一个面部图像数据库,并探讨基于人工智能的面部识别(AI-FR)系统对多种内分泌和代谢综合征的诊断效能及影响因素。
从公共文献和数据库中纳入多种内分泌和代谢综合征患者及健康对照者。在这个面部图像数据库中,收集每个参与者的面部图像和临床数据,并计算 dFRI(疾病面部识别强度)以量化每种综合征的面部复杂性。使用三种算法:支持向量机(SVM)、主成分分析 k-最近邻(PCA-KNN)和自适应增强(AdaBoost),为每种疾病训练 AI-FR 诊断模型。评估诊断性能。选择三种模型中最佳指标作为最优效能。采用回归分析探讨 AI-FR 诊断的影响因素。
纳入 10 种内分泌和代谢综合征的 462 例病例和 2310 例对照者进入面部图像数据库。AI-FR 诊断模型的诊断准确率为 SVM 0.827-0.920、PCA-KNN 0.766-0.890 和 AdaBoost 0.818-0.935。dFRI 越高,最优曲线下面积(AUC)越高(P=0.035)。训练集样本量与诊断性能之间未见显著相关性。
建立了一个包含 10 种内分泌和代谢综合征的多民族、多地区、多疾病的面部数据库。AI-FR 模型显示出理想的诊断性能。dFRI 与诊断性能相关,提示内在面部特征可能有助于 AI-FR 模型的性能。